Total Stories
1
BTC$62,696.00-0.61%
ETH$1,753.33-0.54%
USDT$0.9992-0.01%
USDC$0.99990.00%
XRP$1.09-2.77%
SOL$78.61-2.61%
TRX$0.3296-0.05%
FIGR_HELOC$1.03-0.92%
HYPE$67.90-2.91%
DOGE$0.0725-2.90%
USDS$0.9997+0.00%
RAIN$0.0148-1.35%
LEO$9.43+0.37%
ZEC$479.64+7.75%
WBT$55.61-1.75%
BTC$62,696.00-0.61%
ETH$1,753.33-0.54%
USDT$0.9992-0.01%
USDC$0.99990.00%
XRP$1.09-2.77%
SOL$78.61-2.61%
TRX$0.3296-0.05%
FIGR_HELOC$1.03-0.92%
HYPE$67.90-2.91%
DOGE$0.0725-2.90%
USDS$0.9997+0.00%
RAIN$0.0148-1.35%
LEO$9.43+0.37%
ZEC$479.64+7.75%
WBT$55.61-1.75%
AngioDynamics reported Q2 FY24 with $81.97M in sales and revised annual guidance to $320-$325M amidst market challenges.